Case Study – Secondary Sourcing Strategies to Ensure Supply Chain Security

Case Study – Secondary Sourcing Strategies to Ensure Supply Chain Security

Case Study – Secondary Sourcing Strategies to Ensure Supply Chain Security

What’s in this Case Study

A secondary sourcing strategy is crucial to secure supplies of essential drugs. However, selecting a partner that can meet complex supply, manufacturing and approvals requirements can present a challenge. In this case study, ChiRhoClin was in search of a CDMO to develop a reliable, scalable manufacturing process for its orphan drug product – ChiRhoStim® (Human Secretin for Injection). LLS Health rose to the challenge and is now completing a commercial tech transfer process.  With our first preapproval inspection for an ophthalmic product already complete, LLS Health is ready to take on the ChiRhoStim® product to secure both current and future supply. Download the case study to discover the key factors for a streamlined commercial manufacturing journey and the importance of choosing the right CDMO.

  • ChiRhoStim® is a synthetic hormone and requires an aseptic manufacturing process with sterile filtration followed by lyophilization. In line with ChiRhoClin’s growth ambitions, both small batch manufacture and the capability for scaled-up production were essential.

View The Case Study